AUA Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Hold |
0
| – | – | – | 249 |
|
|
2022
Q4 | – | Sell |
-13
| Closed | -$1K | – | 366 |
|
|
2022
Q3 | $1K | Hold |
13
| – | – | ﹤0.01% | 323 |
|
|
2022
Q2 | $1K | Hold |
13
| – | – | ﹤0.01% | 339 |
|
|
2022
Q1 | $1K | Hold |
13
| – | – | ﹤0.01% | 348 |
|
|
2021
Q4 | $1K | Hold |
13
| – | – | ﹤0.01% | 330 |
|
|
2021
Q3 | $1K | Hold |
13
| – | – | ﹤0.01% | 330 |
|
|
2021
Q2 | $1K | Buy |
13
+1
| +8% | +$77 | ﹤0.01% | 318 |
|
|
2021
Q1 | $1K | Hold |
12
| – | – | ﹤0.01% | 327 |
|
|
2020
Q4 | $1K | Buy |
12
+3
| +33% | +$250 | ﹤0.01% | 322 |
|
|
2020
Q3 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 297 |
|